Influenza, Human  >>  MenHibrix (GSK 792014)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
MenHibrix (GSK 792014) / GSK
NCT00289783: Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine

Completed
3
4441
US, RoW
GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis 792014 vaccine, ActHIB, PedvaxHIB, Pediarix, Infanrix penta, Prevnar, M-M-R II, Varivax
GlaxoSmithKline
Haemophilus Influenzae Type b, Neisseria Meningitidis
08/07
02/08
NCT00345579: Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 2, 4, 6 and 12 to 15 Months of Age

Completed
3
4432
US, RoW
GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine combined 792014, ActHIB, Pediarix/Infanrix Penta
GlaxoSmithKline
Haemophilus Influenzae Type b, Neisseria Meningitidis
10/07
03/08
NCT00359983: Long-Term Antibody Persistence at 1, 3 and 5 Years After a Fourth Dose of GSK Biologicals' Hib-MenCY-TT Vaccine Compared to ActHIB

Completed
3
270
US
MenHibrix (Hib-MenCY-TT), GSK biologicals' Hib-MenCY-TT, Hib conjugate vaccine (ActHIB), ActHIB
GlaxoSmithKline
Neisseria Meningitidis, Haemophilus Influenzae Type b
11/07
05/11
NCT00345683: Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 12 to 15 Months of Age.

Completed
3
4021
US, RoW
GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine combined (792014), PedvaxHIB, Monovalent Hib conjugate vaccine., Prevnar, M-M-R II, Measles, mumps and rubella vaccine., Varivax, Varicella vaccine
GlaxoSmithKline
Haemophilus Influenzae Type b, Neisseria Meningitidis
09/08
11/08
NCT01978093 / 2013-003459-39: Immunogenicity, Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Hib-MenCY-TT (MenHibrix®) Vaccine Compared to Merck & Co, Inc. PedvaxHIB Vaccine in Healthy Infants and Toddlers 12 to 15 Months of Age

Completed
3
600
US
Hib-MenCY-TT (MenHibrix®), Pediarix®, Rotarix®, Prevnar 13®, PedvaxHIB®, Havrix®
GlaxoSmithKline
Neisseria Meningitidis, Haemophilus Influenzae Type b
03/16
03/16

Download Options